DRUG DISCOVERY BIOLOGY & BIOINFORMATICS STRATEGY MEETING EAST COAST USA 2024

Proventa's recent survey of drug discovery biology leaders highlights AI/ML as a top investment priority. Key industry challenges include target identification, in vivo/in vitro pharmacology, and data management. Understanding these trends is crucial for strategic investment decisions in the evolving drug discovery landscape.